These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Triosephosphate isomerase deficiency: a patient with Val231Met mutation.
    Author: Serdaroglu G, Aydinok Y, Yilmaz S, Manco L, Ozer E.
    Journal: Pediatr Neurol; 2011 Feb; 44(2):139-42. PubMed ID: 21215915.
    Abstract:
    Triosephosphate isomerase deficiency constitutes a rare autosomal recessive disorder, characterized by hemolytic anemia, neurodegeneration, and recurrent bacterial infections. It is the most severe glycolytic enzyme defect associated with progressive neurologic dysfunction. Patients with various inherited triosephosphate isomerase deficiency gene mutations were identified. The most frequent is a Glu104Asp mutation, manifested in homozygous and compound heterozygous states. The mutation Val231Met is very rare. We describe a second triosephosphate isomerase-deficient patient homozygous for the Val231Met mutation, with different phenotypic characteristics from the previous case.
    [Abstract] [Full Text] [Related] [New Search]